1. Home
  2. UK vs REVB Comparison

UK vs REVB Comparison

Compare UK & REVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UK
  • REVB
  • Stock Information
  • Founded
  • UK 2015
  • REVB 2020
  • Country
  • UK China
  • REVB United States
  • Employees
  • UK N/A
  • REVB N/A
  • Industry
  • UK Business Services
  • REVB Biotechnology: Pharmaceutical Preparations
  • Sector
  • UK Consumer Discretionary
  • REVB Health Care
  • Exchange
  • UK Nasdaq
  • REVB Nasdaq
  • Market Cap
  • UK 1.7M
  • REVB 1.4M
  • IPO Year
  • UK N/A
  • REVB N/A
  • Fundamental
  • Price
  • UK $1.24
  • REVB $0.65
  • Analyst Decision
  • UK
  • REVB
  • Analyst Count
  • UK 0
  • REVB 0
  • Target Price
  • UK N/A
  • REVB N/A
  • AVG Volume (30 Days)
  • UK 469.1K
  • REVB 6.8M
  • Earning Date
  • UK 02-15-2025
  • REVB 11-08-2024
  • Dividend Yield
  • UK N/A
  • REVB N/A
  • EPS Growth
  • UK N/A
  • REVB N/A
  • EPS
  • UK N/A
  • REVB N/A
  • Revenue
  • UK $42,470,655.00
  • REVB N/A
  • Revenue This Year
  • UK N/A
  • REVB N/A
  • Revenue Next Year
  • UK N/A
  • REVB N/A
  • P/E Ratio
  • UK N/A
  • REVB N/A
  • Revenue Growth
  • UK N/A
  • REVB N/A
  • 52 Week Low
  • UK $1.04
  • REVB $0.28
  • 52 Week High
  • UK $5.55
  • REVB $25.26
  • Technical
  • Relative Strength Index (RSI)
  • UK 53.79
  • REVB 62.80
  • Support Level
  • UK $1.11
  • REVB $0.28
  • Resistance Level
  • UK $1.39
  • REVB $1.26
  • Average True Range (ATR)
  • UK 0.12
  • REVB 0.12
  • MACD
  • UK 0.01
  • REVB 0.05
  • Stochastic Oscillator
  • UK 57.14
  • REVB 37.39

About UK Ucommune International Ltd

Ucommune International Ltd is a flexible office space provider and manager based in the People's Republic of China (PRC). The company offers long-term leasing, on-demand, and short-term leasing solutions to freelancers, start-up entrepreneurs, small and medium enterprises, and corporations. They provide fully-serviced and well-furnished office spaces on a flexible basis. The members of the Ucommune community, which includes individuals and enterprises registered on the U bazaar mobile app, can avail of these services. The company has three operating segments: Workspace membership, Marketing and branding services, and Other services. Marketing and branding services generate the majority of the company's revenue.

About REVB Revelation Biosciences Inc.

Revelation Biosciences Inc is a clinical-stage life sciences company focused on the development of therapies for the prevention and treatment of disease using trained immunity. It is developing a pipeline of potential high-value products based on Gemini. Gemini is Revelation's proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD) an established TLR4 agonist that can stimulate the human body's innate immune response to prevent and treat disease. The product candidates are developed are based on Gemini formulation of PHAD. Gemini based programs consist of: Gemini-SSI developed for the prevention of surgical site infection (SSI); Gemini-AKI developed for the prevention of acute kidney injury (AKI); and Gemini-CKD for the treatment of chronic kidney disease (CKD).

Share on Social Networks: